Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Mechanisms of translational deregulation in human tumors and therapeutic intervention strategies.

Bilanges B, Stokoe D.

Oncogene. 2007 Sep 6;26(41):5973-90. Epub 2007 Apr 2. Review.

PMID:
17404576
2.

The mammalian target of rapamycin (mTOR) pathway regulates mitochondrial oxygen consumption and oxidative capacity.

Schieke SM, Phillips D, McCoy JP Jr, Aponte AM, Shen RF, Balaban RS, Finkel T.

J Biol Chem. 2006 Sep 15;281(37):27643-52. Epub 2006 Jul 17.

3.

Activation of transferrin receptor 1 by c-Myc enhances cellular proliferation and tumorigenesis.

O'Donnell KA, Yu D, Zeller KI, Kim JW, Racke F, Thomas-Tikhonenko A, Dang CV.

Mol Cell Biol. 2006 Mar;26(6):2373-86.

4.

TOR signaling in growth and metabolism.

Wullschleger S, Loewith R, Hall MN.

Cell. 2006 Feb 10;124(3):471-84. Review.

5.

Microarrays of lentiviruses for gene function screens in immortalized and primary cells.

Bailey SN, Ali SM, Carpenter AE, Higgins CO, Sabatini DM.

Nat Methods. 2006 Feb;3(2):117-22.

PMID:
16432521
6.

STIM is a Ca2+ sensor essential for Ca2+-store-depletion-triggered Ca2+ influx.

Liou J, Kim ML, Heo WD, Jones JT, Myers JW, Ferrell JE Jr, Meyer T.

Curr Biol. 2005 Jul 12;15(13):1235-41.

7.

Genome-wide analysis of human kinases in clathrin- and caveolae/raft-mediated endocytosis.

Pelkmans L, Fava E, Grabner H, Hannus M, Habermann B, Krausz E, Zerial M.

Nature. 2005 Jul 7;436(7047):78-86. Epub 2005 May 11.

8.

CDD: a Conserved Domain Database for protein classification.

Marchler-Bauer A, Anderson JB, Cherukuri PF, DeWeese-Scott C, Geer LY, Gwadz M, He S, Hurwitz DI, Jackson JD, Ke Z, Lanczycki CJ, Liebert CA, Liu C, Lu F, Marchler GH, Mullokandov M, Shoemaker BA, Simonyan V, Song JS, Thiessen PA, Yamashita RA, Yin JJ, Zhang D, Bryant SH.

Nucleic Acids Res. 2005 Jan 1;33(Database issue):D192-6.

9.

Upstream and downstream of mTOR.

Hay N, Sonenberg N.

Genes Dev. 2004 Aug 15;18(16):1926-45. Review.

10.

mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways.

Majumder PK, Febbo PG, Bikoff R, Berger R, Xue Q, McMahon LM, Manola J, Brugarolas J, McDonnell TJ, Golub TR, Loda M, Lane HA, Sellers WR.

Nat Med. 2004 Jun;10(6):594-601. Epub 2004 May 23.

PMID:
15156201
11.

Balancing acts: molecular control of mammalian iron metabolism.

Hentze MW, Muckenthaler MU, Andrews NC.

Cell. 2004 Apr 30;117(3):285-97. Review.

12.

Probing the precision of the mitotic clock with a live-cell fluorescent biosensor.

Jones JT, Myers JW, Ferrell JE, Meyer T.

Nat Biotechnol. 2004 Mar;22(3):306-12. Epub 2004 Feb 8.

PMID:
14990952
13.

Labile iron pool: the main determinant of cellular response to oxidative stress.

Kruszewski M.

Mutat Res. 2003 Oct 29;531(1-2):81-92. Review.

PMID:
14637247
14.

AKT activity determines sensitivity to mammalian target of rapamycin (mTOR) inhibitors by regulating cyclin D1 and c-myc expression.

Gera JF, Mellinghoff IK, Shi Y, Rettig MB, Tran C, Hsu JH, Sawyers CL, Lichtenstein AK.

J Biol Chem. 2004 Jan 23;279(4):2737-46. Epub 2003 Oct 23.

15.
16.

Selective regulation of neurite extension and synapse formation by the beta but not the alpha isoform of CaMKII.

Fink CC, Bayer KU, Myers JW, Ferrell JE Jr, Schulman H, Meyer T.

Neuron. 2003 Jul 17;39(2):283-97.

17.

GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR.

Kim DH, Sarbassov DD, Ali SM, Latek RR, Guntur KV, Erdjument-Bromage H, Tempst P, Sabatini DM.

Mol Cell. 2003 Apr;11(4):895-904.

18.
19.

The prostate-derived sterile 20-like kinase (PSK) regulates microtubule organization and stability.

Mitsopoulos C, Zihni C, Garg R, Ridley AJ, Morris JD.

J Biol Chem. 2003 May 16;278(20):18085-91. Epub 2003 Mar 13.

20.

Regulated portals of entry into the cell.

Conner SD, Schmid SL.

Nature. 2003 Mar 6;422(6927):37-44. Review.

PMID:
12621426

Supplemental Content

Support Center